USA Oncology Biomarker Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Oncology Biomarker market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Oncology Biomarker market. Detailed analysis of key players, along with key growth strategies adopted by Oncology Biomarker industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Genomic Health, Inc

    • Bristol-Myers Squibb

    • GlaxoSmithKline plc

    • Pfizer, Inc

    • Eli Lilly and Company FHoffmann-La Roche Ltd

    • Merck & Co, Inc

    • Qiagen NV

    • Novartis AG

    • Abbott Laboratories

    By Type:

    • Lung Cancer

    • Breast Cancer

    • Colorectal Cancer

    • Prostate Cancer

    • Stomach Cancer

    • Others

    By End-User:

    • Diagnostics

    • Drug Discovery and Development

    • Prognostics

    • Risk Assessment

    • Others

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Oncology Biomarker Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Oncology Biomarker Market Size and Growth Rate of Lung Cancer from 2016 to 2027

      • 1.3.2 USA Oncology Biomarker Market Size and Growth Rate of Breast Cancer from 2016 to 2027

      • 1.3.3 USA Oncology Biomarker Market Size and Growth Rate of Colorectal Cancer from 2016 to 2027

      • 1.3.4 USA Oncology Biomarker Market Size and Growth Rate of Prostate Cancer from 2016 to 2027

      • 1.3.5 USA Oncology Biomarker Market Size and Growth Rate of Stomach Cancer from 2016 to 2027

      • 1.3.6 USA Oncology Biomarker Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Oncology Biomarker Market Size and Growth Rate of Diagnostics from 2016 to 2027

      • 1.4.2 USA Oncology Biomarker Market Size and Growth Rate of Drug Discovery and Development from 2016 to 2027

      • 1.4.3 USA Oncology Biomarker Market Size and Growth Rate of Prognostics from 2016 to 2027

      • 1.4.4 USA Oncology Biomarker Market Size and Growth Rate of Risk Assessment from 2016 to 2027

      • 1.4.5 USA Oncology Biomarker Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Oncology Biomarker Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Oncology Biomarker Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Oncology Biomarker Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Oncology Biomarker Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Oncology Biomarker Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Oncology Biomarker by Major Types

      • 3.4.1 Market Size and Growth Rate of Lung Cancer

      • 3.4.2 Market Size and Growth Rate of Breast Cancer

      • 3.4.3 Market Size and Growth Rate of Colorectal Cancer

      • 3.4.4 Market Size and Growth Rate of Prostate Cancer

      • 3.4.5 Market Size and Growth Rate of Stomach Cancer

      • 3.4.6 Market Size and Growth Rate of Others

    4 Segmentation of Oncology Biomarker Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Oncology Biomarker by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Oncology Biomarker in Diagnostics

      • 4.4.2 Market Size and Growth Rate of Oncology Biomarker in Drug Discovery and Development

      • 4.4.3 Market Size and Growth Rate of Oncology Biomarker in Prognostics

      • 4.4.4 Market Size and Growth Rate of Oncology Biomarker in Risk Assessment

      • 4.4.5 Market Size and Growth Rate of Oncology Biomarker in Others

    5 Market Analysis by Regions

    • 5.1 USA Oncology Biomarker Production Analysis by Regions

    • 5.2 USA Oncology Biomarker Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Oncology Biomarker Landscape Analysis

    • 6.1 West USA Oncology Biomarker Landscape Analysis by Major Types

    • 6.2 West USA Oncology Biomarker Landscape Analysis by Major End-Users

    7 South USA Oncology Biomarker Landscape Analysis

    • 7.1 South USA Oncology Biomarker Landscape Analysis by Major Types

    • 7.2 South USA Oncology Biomarker Landscape Analysis by Major End-Users

    8 Middle West USA Oncology Biomarker Landscape Analysis

    • 8.1 Middle West USA Oncology Biomarker Landscape Analysis by Major Types

    • 8.2 Middle West USA Oncology Biomarker Landscape Analysis by Major End-Users

    9 Northeast USA Oncology Biomarker Landscape Analysis

    • 9.1 Northeast USA Oncology Biomarker Landscape Analysis by Major Types

    • 9.2 Northeast USA Oncology Biomarker Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Genomic Health, Inc

        • 10.1.1 Genomic Health, Inc Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Bristol-Myers Squibb

        • 10.2.1 Bristol-Myers Squibb Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 GlaxoSmithKline plc

        • 10.3.1 GlaxoSmithKline plc Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Pfizer, Inc

        • 10.4.1 Pfizer, Inc Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Eli Lilly and Company FHoffmann-La Roche Ltd

        • 10.5.1 Eli Lilly and Company FHoffmann-La Roche Ltd Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Merck & Co, Inc

        • 10.6.1 Merck & Co, Inc Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Qiagen NV

        • 10.7.1 Qiagen NV Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Novartis AG

        • 10.8.1 Novartis AG Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Abbott Laboratories

        • 10.9.1 Abbott Laboratories Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Oncology Biomarker Market Size and Growth Rate of Lung Cancer from 2016 to 2027

    • Figure USA Oncology Biomarker Market Size and Growth Rate of Breast Cancer from 2016 to 2027

    • Figure USA Oncology Biomarker Market Size and Growth Rate of Colorectal Cancer from 2016 to 2027

    • Figure USA Oncology Biomarker Market Size and Growth Rate of Prostate Cancer from 2016 to 2027

    • Figure USA Oncology Biomarker Market Size and Growth Rate of Stomach Cancer from 2016 to 2027

    • Figure USA Oncology Biomarker Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Oncology Biomarker Market Size and Growth Rate of Diagnostics from 2016 to 2027

    • Figure USA Oncology Biomarker Market Size and Growth Rate of Drug Discovery and Development from 2016 to 2027

    • Figure USA Oncology Biomarker Market Size and Growth Rate of Prognostics from 2016 to 2027

    • Figure USA Oncology Biomarker Market Size and Growth Rate of Risk Assessment from 2016 to 2027

    • Figure USA Oncology Biomarker Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Oncology Biomarker Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Oncology Biomarker Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Oncology Biomarker Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Oncology Biomarker Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Oncology Biomarker Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Oncology Biomarker

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Oncology Biomarker by Different Types from 2016 to 2027

    • Table Consumption Share of Oncology Biomarker by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Lung Cancer

    • Figure Market Size and Growth Rate of Breast Cancer

    • Figure Market Size and Growth Rate of Colorectal Cancer

    • Figure Market Size and Growth Rate of Prostate Cancer

    • Figure Market Size and Growth Rate of Stomach Cancer

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Oncology Biomarker by Different End-Users from 2016 to 2027

    • Table Consumption Share of Oncology Biomarker by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Diagnostics

    • Figure Market Size and Growth Rate of Drug Discovery and Development

    • Figure Market Size and Growth Rate of Prognostics

    • Figure Market Size and Growth Rate of Risk Assessment

    • Figure Market Size and Growth Rate of Others

    • Table USA Oncology Biomarker Production by Regions

    • Table USA Oncology Biomarker Production Share by Regions

    • Figure USA Oncology Biomarker Production Share by Regions in 2016

    • Figure USA Oncology Biomarker Production Share by Regions in 2021

    • Figure USA Oncology Biomarker Production Share by Regions in 2027

    • Table USA Oncology Biomarker Consumption by Regions

    • Table USA Oncology Biomarker Consumption Share by Regions

    • Figure USA Oncology Biomarker Consumption Share by Regions in 2016

    • Figure USA Oncology Biomarker Consumption Share by Regions in 2021

    • Figure USA Oncology Biomarker Consumption Share by Regions in 2027

    • Table West USA Oncology Biomarker Consumption by Types from 2016 to 2027

    • Table West USA Oncology Biomarker Consumption Share by Types from 2016 to 2027

    • Figure West USA Oncology Biomarker Consumption Share by Types in 2016

    • Figure West USA Oncology Biomarker Consumption Share by Types in 2021

    • Figure West USA Oncology Biomarker Consumption Share by Types in 2027

    • Table West USA Oncology Biomarker Consumption by End-Users from 2016 to 2027

    • Table West USA Oncology Biomarker Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Oncology Biomarker Consumption Share by End-Users in 2016

    • Figure West USA Oncology Biomarker Consumption Share by End-Users in 2021

    • Figure West USA Oncology Biomarker Consumption Share by End-Users in 2027

    • Table South USA Oncology Biomarker Consumption by Types from 2016 to 2027

    • Table South USA Oncology Biomarker Consumption Share by Types from 2016 to 2027

    • Figure South USA Oncology Biomarker Consumption Share by Types in 2016

    • Figure South USA Oncology Biomarker Consumption Share by Types in 2021

    • Figure South USA Oncology Biomarker Consumption Share by Types in 2027

    • Table South USA Oncology Biomarker Consumption by End-Users from 2016 to 2027

    • Table South USA Oncology Biomarker Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Oncology Biomarker Consumption Share by End-Users in 2016

    • Figure South USA Oncology Biomarker Consumption Share by End-Users in 2021

    • Figure South USA Oncology Biomarker Consumption Share by End-Users in 2027

    • Table Middle West USA Oncology Biomarker Consumption by Types from 2016 to 2027

    • Table Middle West USA Oncology Biomarker Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Oncology Biomarker Consumption Share by Types in 2016

    • Figure Middle West USA Oncology Biomarker Consumption Share by Types in 2021

    • Figure Middle West USA Oncology Biomarker Consumption Share by Types in 2027

    • Table Middle West USA Oncology Biomarker Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Oncology Biomarker Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Oncology Biomarker Consumption Share by End-Users in 2016

    • Figure Middle West USA Oncology Biomarker Consumption Share by End-Users in 2021

    • Figure Middle West USA Oncology Biomarker Consumption Share by End-Users in 2027

    • Table Northeast USA Oncology Biomarker Consumption by Types from 2016 to 2027

    • Table Northeast USA Oncology Biomarker Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Oncology Biomarker Consumption Share by Types in 2016

    • Figure Northeast USA Oncology Biomarker Consumption Share by Types in 2021

    • Figure Northeast USA Oncology Biomarker Consumption Share by Types in 2027

    • Table Northeast USA Oncology Biomarker Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Oncology Biomarker Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Oncology Biomarker Consumption Share by End-Users in 2016

    • Figure Northeast USA Oncology Biomarker Consumption Share by End-Users in 2021

    • Figure Northeast USA Oncology Biomarker Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Genomic Health, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genomic Health, Inc

    • Figure Sales and Growth Rate Analysis of Genomic Health, Inc

    • Figure Revenue and Market Share Analysis of Genomic Health, Inc

    • Table Product and Service Introduction of Genomic Health, Inc

    • Table Company Profile and Development Status of Bristol-Myers Squibb

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb

    • Table Product and Service Introduction of Bristol-Myers Squibb

    • Table Company Profile and Development Status of GlaxoSmithKline plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline plc

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline plc

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline plc

    • Table Product and Service Introduction of GlaxoSmithKline plc

    • Table Company Profile and Development Status of Pfizer, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer, Inc

    • Figure Sales and Growth Rate Analysis of Pfizer, Inc

    • Figure Revenue and Market Share Analysis of Pfizer, Inc

    • Table Product and Service Introduction of Pfizer, Inc

    • Table Company Profile and Development Status of Eli Lilly and Company FHoffmann-La Roche Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Company FHoffmann-La Roche Ltd

    • Figure Sales and Growth Rate Analysis of Eli Lilly and Company FHoffmann-La Roche Ltd

    • Figure Revenue and Market Share Analysis of Eli Lilly and Company FHoffmann-La Roche Ltd

    • Table Product and Service Introduction of Eli Lilly and Company FHoffmann-La Roche Ltd

    • Table Company Profile and Development Status of Merck & Co, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co, Inc

    • Figure Sales and Growth Rate Analysis of Merck & Co, Inc

    • Figure Revenue and Market Share Analysis of Merck & Co, Inc

    • Table Product and Service Introduction of Merck & Co, Inc

    • Table Company Profile and Development Status of Qiagen NV

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Qiagen NV

    • Figure Sales and Growth Rate Analysis of Qiagen NV

    • Figure Revenue and Market Share Analysis of Qiagen NV

    • Table Product and Service Introduction of Qiagen NV

    • Table Company Profile and Development Status of Novartis AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

    • Figure Sales and Growth Rate Analysis of Novartis AG

    • Figure Revenue and Market Share Analysis of Novartis AG

    • Table Product and Service Introduction of Novartis AG

    • Table Company Profile and Development Status of Abbott Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories

    • Figure Sales and Growth Rate Analysis of Abbott Laboratories

    • Figure Revenue and Market Share Analysis of Abbott Laboratories

    • Table Product and Service Introduction of Abbott Laboratories


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.